The Wearable Robotic Exoskeleton market, valued at USD 2,058.4 million in 2024, is expected to register robust revenue CAGR of 32.8%.

(MENAFN- Navistrat Analytics) 02nd July 2025 - Technological advancements in robotics and materials science is a key driver driving wearable robotic exoskeleton market revenue growth. The landscape of wearable robotics and exoskeletons has changed considerably in recent years, thanks to substantial developments in materials science, robotics, and artificial intelligence. Modern advances have changed these technologies from experimental prototypes to highly functional, practical products that are having a significant influence across a variety of industries.

On December 2022, Ekso Bionics, the market leader in exoskeleton technology for medical and industrial applications, has announced the acquisition of Parker Hannifin Corporation's Human Motion and Control Business Unit. The acquisition includes the Indego lower limb exoskeleton product line, as well as plans to create robotic-assisted orthotic and prosthetic devices.

Despite substantial advances in wearable robots and their transformational impact on medical rehabilitation and assistive technologies, a number of obstacles and issues must be addressed in order to optimize their benefits and ensure their appropriate integration into clinical practice. One of the most significant difficulties is the question of affordability and accessibility. Wearable robots, particularly advanced exoskeletons, can be prohibitively expensive because to the high expenses of research & development, materials, and production. The high expense of these gadgets makes it difficult for healthcare systems and rehabilitation facilities to include them into their routine treatment programs.

Want to Know What’s Fueling the Wearable Robotic Exoskeleton Market Growth? Get Exclusive Report Insights Here:

Segments market overview and growth Insights
Based on the type, the Wearable Robotic Exoskeleton market is segmented into powered and passive. The gene therapies segment held the largest market share in 2024. These devices are intended to support, augment, or replace the wearer's physical abilities, allowing people with a variety of disabilities to participate more completely in daily activities and interactions. Wearable robotics can lessen reliance on wheelchairs and other mobility aids by allowing people to assume an upright posture and move more freely, resulting in a more active and participative lifestyle. This increased mobility can have major psychological benefits, including higher self-esteem and a stronger sense of autonomy.

Regional market overview and growth insights
North America held the largest market share in the Wearable Robotic Exoskeleton market in 2024, due to development of AI-powered adaptive systems. On February 2025, DIH Holding US, Inc., a global manufacturer of innovative robotic devices for rehabilitation, has expanded its strategic cooperation with Zahrawi Group, DIH's agent and sales partner, to cover Saudi Arabia. The expansion seeks to improve the distribution and accessibility of DIH's unique rehabilitation solutions in these locations, using Zahrawi Group's existing presence and expertise in the healthcare industry.

Competitive Landscape and Key Competitors
The Wearable Robotic Exoskeleton market is characterized by a fragmented structure, with many competitors holding a significant share of the market. List of major players included in the Wearable Robotic Exoskeleton market report are:

o Bionik Laboratories Corp
o Ottobock
o Hocoma
o Lockheed Martin Corporation
o ReWalk Robotics
o Comau
o Hyundai Motor Company
o Rex Bionics Ltd.
o Cyberdyne, Inc.
o Parker Hannifin Corporation
o Ekso Bionics
o Wearable Robotics
o Celera Motion
o Hypershell
o Trexo Robotics

Buy Your Exclusive Copy Now:

Major strategic developments by leading competitors
Auxivo: On July 2024, Auxivo introduced the new Auxivo EduExo Pro. The EduExo Pro is Auxivo's latest sophisticated educational exoskeleton kit, designed to provide universities and other educational institutions with a simple and straightforward approach to incorporate exoskeleton technology into higher education and research. The EduExo Pro provides a project-based exoskeleton learning experience that encourages critical thinking, creativity, and collaboration among students from a variety of disciplines, including engineering, health sciences, and medicine.

Wandercraft: In January 2022, Wandercraft, a French robotic exoskeleton developer, are looking to expand into the United States with a USD 45 million Series C. The business will be competing in a crowded market in the United States, which is home to several famous exoskeleton companies such as ReWalk Robotics, Ekso, SuitX, and Sarcos, all of which have raised significant funds and announced high-profile partnerships.

Unlock the Key to Transforming Your Business Strategy with Our Wearable Robotic Exoskeleton Market Insights –
• Download the report summary:
• Request customization:

Navistrat Analytics has segmented wearable robotic exoskeleton market based on type, component, body part, power source, and application:

• Type Outlook (Revenue, USD Million; 2022-2032)
o Powered
o Passive

• Component Outlook (Revenue, USD Million; 2022-2032)
o Hardware
o Software

• Body Part Outlook (Revenue, USD Million; 2022-2032)
o Upper Body
o Lower Body
o Full Body

• Power Source Outlook (Revenue, USD Million; 2022-2032)
o Hydraulic
o Pneumatic
o Electric
o Hybrid

• Application Outlook (Revenue, USD Million; 2022-2032)
o Healthcare and Rehabilitation
o Industrial
o Military & Defense
o Sports & Athletics
o Others

• Regional Outlook (Revenue, USD Million; 2022-2032)
o North America
a. U.S.
b. Canada
c. Mexico

o Europe
a. Germany
b. France
c. U.K.
d. Italy
e. Spain
f. Benelux
g. Nordic Countries
h. Rest of Europe

o Asia Pacific
a. China
b. India
c. Japan
d. South Korea
e. Oceania
f. ASEAN Countries
g. Rest of APAC

o Latin America
a. Brazil
b. Rest of LATAM

o Middle East & Africa
a. GCC Countries
b. South Africa
c. Israel
d. Turkey
e. Rest of MEA

Get a preview of the complete research study:

MENAFN02072025008152017457ID1109751796